HIGHLIGHTS
- who: Chiara Zichittella from the (UNIVERSITY) have published the research: Mir-675-5p supports hypoxia-induced drug resistance in colorectal cancer cells, in the Journal: (JOURNAL)
- what: Our in_vitro data unveiled a possible role for the hypoxiainduced miR-675-5p as a promoter of 5-FU drug resistance.
- how: The data indicated that in prolonged hypoxia the miR-675-5p may promote cell viability in multiple ways.
- future: The data suggested that the combined action of the drug and AntagomiR675-5p could lead to a decrease in therapeutic drug doses but . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.